[Clinical study of a new cephalosporin: ceftriaxone (RO 13-9904) in resurgent acute and chronic bronchopneumopathies].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001982:Bronchial Diseases / Q000188:drug therapy*; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002443:Ceftriaxone; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence
D002443:Ceftriaxone; D002439:Cefotaxime
Studo clinico di una nuova cefalosporina: il ceftriaxone (RO 13-9904) nelle broncopneumopatie acute e croniche riacutizzate.